Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Vodobatinib - Sun Pharma Advanced Research Company

Next Previous
X
Search
Drug Profile

Vodobatinib - Sun Pharma Advanced Research Company

Alternative Names: K-0706; SCO-088; SUN K706; SUN-K0706

Latest Information Update: 02 Aug 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Sun Pharma Advanced Research Company
  • Class Antidementias; Antineoplastics; Antiparkinsonians; Benzoic acids; Chlorinated hydrocarbons; Quinolines; Small molecules
  • Mechanism of Action Bcr-Abl tyrosine kinase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Lewy body disease; Parkinson's disease
  • Phase I/II Chronic myeloid leukaemia; Precursor B-cell lymphoblastic leukaemia-lymphoma

Most Recent Events

  • 06 Jun 2024 Sun Pharma terminates Phase-II clinical trials in Parkinson's disease (In the elderly) in USA (PO) due to study outcomes (NCT03655236)
  • 25 Jul 2022 Vodobatinib is still in phase II trials for Lewy body disease (In the elderly, Treatment-experienced, In adults) in USA (PO) (NCT03996460)
  • 05 Dec 2020 Interim adverse events and efficacy data from a phase I/II trial in Chronic Myeloid Leukemia presented at the 62nd Annual Meeting and Exposition of the American Society of Hematology (ASH-2020)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top